Application Nr Approved Date Route Status External Links
ANDA075861 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage For The Acute And Chronic Treatment Of Patients With An Inborn Error Of Metabolism Which Results In Secondary Carnitine Deficiency.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levocarnitine LEVOCARNITINE ZINC3079340

Comments